Summary
The compound IBI-P-05006, 2-(6’-carboxyhexyl)-3-n-hexylcyclohexylamine, is an antiaggregating agent under development. IBI-P-05006 is an in vitro inhibitor of platelet aggregation. The biotransformation of this compound has been studied in the dog and rat We present here a study on the metabolites of IBI-P-05006 found in dog and rat urine, and in dog plasma. Analyses were done by gas chromatography-mass spectrometry.
In dog urine 15 metabolites were identified. Some of them were also found in dog plasma and in rat urine. The unmetabolized drug was found only in plasma. 10 different hydroxylated metabolites were characterized. The hydroxyl groups were introduced in the hexyl chain in positions (ω-4, ω -3, ω -2, ω -1 and ω.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Valcavi U. (1987): Italian Pat Appl. 21055A/87.
Valcavi U. (1989): Pat IT 1205183.
Benfenati E., Fanelli R., Chiabrando C, Valcavi U., Bosone E., Farina P. (1988): Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (Rosaprostol). Prostaglandins, 35, 665–684.
Raaijmakers J.G.A.M. (1977): System for the identification of novel prostaglandins. J. Chromatogr., 138, 355–372.
Budzikiewicz H., Djerassi C, Wilhams D.H. (1967): Mass Spectrometry of Organic Compounds. San Fransisco, Holden-Day, p. 471.
Kuhara T., Matsumoto I. (1974): Metabolism of branched medium chain length fatty acid. I. (ω-Oxidation of sodium dipropylacetate in rats. Biomed. Mass Spectrom, 1, 291–294.
Sun F.F., Taylor B.M. (1978): Metabolism of prostacyclin in rat. Biochemistry, 17, 4096–4101.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benfenati, E., Fanelli, R., Bosone, E. et al. Mass spectrometric identification of urinary and plasma metabolites of 2-(6’-carboxyhexyl)-3-n-hexylcyclohexylamine, a new antiaggregating agent. Eur. J. Drug Metab. Pharmacokinet. 17, 93–101 (1992). https://doi.org/10.1007/BF03188777
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03188777